Cargando…
Toward a Practical, Nonenzymatic Process for Investigational COVID-19 Antiviral Molnupiravir from Cytidine: Supply-Centered Synthesis
[Image: see text] A scalable four-step synthesis of molnupiravir from cytidine is described herein. The attractiveness of this approach is its fully chemical nature involving inexpensive reagents and more environmentally friendly solvents such as water, isopropanol, acetonitrile, and acetone. Isolat...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689649/ https://www.ncbi.nlm.nih.gov/pubmed/34955627 http://dx.doi.org/10.1021/acs.oprd.1c00219 |
_version_ | 1784618579146047488 |
---|---|
author | Gopalsamuthiram, Vijayagopal Kadam, Appasaheb L. Noble, Jeffrey K. Snead, David R. Williams, Corshai Jamison, Timothy F. Senanayake, Chris Yadaw, Ajay K. Roy, Sarabindu Sirasani, Gopal Gupton, B. Frank Burns, Justina Cook, Daniel W. Stringham, Rodger W. Ahmad, Saeed Krack, Rudy |
author_facet | Gopalsamuthiram, Vijayagopal Kadam, Appasaheb L. Noble, Jeffrey K. Snead, David R. Williams, Corshai Jamison, Timothy F. Senanayake, Chris Yadaw, Ajay K. Roy, Sarabindu Sirasani, Gopal Gupton, B. Frank Burns, Justina Cook, Daniel W. Stringham, Rodger W. Ahmad, Saeed Krack, Rudy |
author_sort | Gopalsamuthiram, Vijayagopal |
collection | PubMed |
description | [Image: see text] A scalable four-step synthesis of molnupiravir from cytidine is described herein. The attractiveness of this approach is its fully chemical nature involving inexpensive reagents and more environmentally friendly solvents such as water, isopropanol, acetonitrile, and acetone. Isolation and purification procedures are improved in comparison to our earlier study as all intermediates can be isolated via recrystallization. The key steps in the synthesis, namely, ester formation, hydroxyamination, and deprotection were carried out on a multigram scale to afford molnupiravir in 36–41% yield with an average purity of 98 wt % by qNMR and 99 area% by HPLC. |
format | Online Article Text |
id | pubmed-8689649 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-86896492021-12-22 Toward a Practical, Nonenzymatic Process for Investigational COVID-19 Antiviral Molnupiravir from Cytidine: Supply-Centered Synthesis Gopalsamuthiram, Vijayagopal Kadam, Appasaheb L. Noble, Jeffrey K. Snead, David R. Williams, Corshai Jamison, Timothy F. Senanayake, Chris Yadaw, Ajay K. Roy, Sarabindu Sirasani, Gopal Gupton, B. Frank Burns, Justina Cook, Daniel W. Stringham, Rodger W. Ahmad, Saeed Krack, Rudy Org Process Res Dev [Image: see text] A scalable four-step synthesis of molnupiravir from cytidine is described herein. The attractiveness of this approach is its fully chemical nature involving inexpensive reagents and more environmentally friendly solvents such as water, isopropanol, acetonitrile, and acetone. Isolation and purification procedures are improved in comparison to our earlier study as all intermediates can be isolated via recrystallization. The key steps in the synthesis, namely, ester formation, hydroxyamination, and deprotection were carried out on a multigram scale to afford molnupiravir in 36–41% yield with an average purity of 98 wt % by qNMR and 99 area% by HPLC. American Chemical Society 2021-12-09 2021-12-17 /pmc/articles/PMC8689649/ /pubmed/34955627 http://dx.doi.org/10.1021/acs.oprd.1c00219 Text en © 2021 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Gopalsamuthiram, Vijayagopal Kadam, Appasaheb L. Noble, Jeffrey K. Snead, David R. Williams, Corshai Jamison, Timothy F. Senanayake, Chris Yadaw, Ajay K. Roy, Sarabindu Sirasani, Gopal Gupton, B. Frank Burns, Justina Cook, Daniel W. Stringham, Rodger W. Ahmad, Saeed Krack, Rudy Toward a Practical, Nonenzymatic Process for Investigational COVID-19 Antiviral Molnupiravir from Cytidine: Supply-Centered Synthesis |
title | Toward a Practical, Nonenzymatic Process for Investigational
COVID-19 Antiviral Molnupiravir from Cytidine: Supply-Centered Synthesis |
title_full | Toward a Practical, Nonenzymatic Process for Investigational
COVID-19 Antiviral Molnupiravir from Cytidine: Supply-Centered Synthesis |
title_fullStr | Toward a Practical, Nonenzymatic Process for Investigational
COVID-19 Antiviral Molnupiravir from Cytidine: Supply-Centered Synthesis |
title_full_unstemmed | Toward a Practical, Nonenzymatic Process for Investigational
COVID-19 Antiviral Molnupiravir from Cytidine: Supply-Centered Synthesis |
title_short | Toward a Practical, Nonenzymatic Process for Investigational
COVID-19 Antiviral Molnupiravir from Cytidine: Supply-Centered Synthesis |
title_sort | toward a practical, nonenzymatic process for investigational
covid-19 antiviral molnupiravir from cytidine: supply-centered synthesis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689649/ https://www.ncbi.nlm.nih.gov/pubmed/34955627 http://dx.doi.org/10.1021/acs.oprd.1c00219 |
work_keys_str_mv | AT gopalsamuthiramvijayagopal towardapracticalnonenzymaticprocessforinvestigationalcovid19antiviralmolnupiravirfromcytidinesupplycenteredsynthesis AT kadamappasahebl towardapracticalnonenzymaticprocessforinvestigationalcovid19antiviralmolnupiravirfromcytidinesupplycenteredsynthesis AT noblejeffreyk towardapracticalnonenzymaticprocessforinvestigationalcovid19antiviralmolnupiravirfromcytidinesupplycenteredsynthesis AT sneaddavidr towardapracticalnonenzymaticprocessforinvestigationalcovid19antiviralmolnupiravirfromcytidinesupplycenteredsynthesis AT williamscorshai towardapracticalnonenzymaticprocessforinvestigationalcovid19antiviralmolnupiravirfromcytidinesupplycenteredsynthesis AT jamisontimothyf towardapracticalnonenzymaticprocessforinvestigationalcovid19antiviralmolnupiravirfromcytidinesupplycenteredsynthesis AT senanayakechris towardapracticalnonenzymaticprocessforinvestigationalcovid19antiviralmolnupiravirfromcytidinesupplycenteredsynthesis AT yadawajayk towardapracticalnonenzymaticprocessforinvestigationalcovid19antiviralmolnupiravirfromcytidinesupplycenteredsynthesis AT roysarabindu towardapracticalnonenzymaticprocessforinvestigationalcovid19antiviralmolnupiravirfromcytidinesupplycenteredsynthesis AT sirasanigopal towardapracticalnonenzymaticprocessforinvestigationalcovid19antiviralmolnupiravirfromcytidinesupplycenteredsynthesis AT guptonbfrank towardapracticalnonenzymaticprocessforinvestigationalcovid19antiviralmolnupiravirfromcytidinesupplycenteredsynthesis AT burnsjustina towardapracticalnonenzymaticprocessforinvestigationalcovid19antiviralmolnupiravirfromcytidinesupplycenteredsynthesis AT cookdanielw towardapracticalnonenzymaticprocessforinvestigationalcovid19antiviralmolnupiravirfromcytidinesupplycenteredsynthesis AT stringhamrodgerw towardapracticalnonenzymaticprocessforinvestigationalcovid19antiviralmolnupiravirfromcytidinesupplycenteredsynthesis AT ahmadsaeed towardapracticalnonenzymaticprocessforinvestigationalcovid19antiviralmolnupiravirfromcytidinesupplycenteredsynthesis AT krackrudy towardapracticalnonenzymaticprocessforinvestigationalcovid19antiviralmolnupiravirfromcytidinesupplycenteredsynthesis |